Cameron John Reynolds, President and CEO at VOLITIONRX LTD (VNRX), bought 20,000 shares at $0.44 ($9K) on 2025-05-19, disclosed to the SEC on 2025-05-19.
Open-market purchase of $9k VNRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| VNRX | BUY | 2025-09-15 | $10K | — | Filing → |
| VNRX | BUY | 2025-08-06 | $50K | — | Filing → |
| VNRX | BUY | 2025-06-16 | $7K | — | Filing → |